Burzynski Research Institute, Inc.
|
-0.01 USD
|
-1225096.078%
|
Arch Therapeutics, Inc.
|
-2.27 USD
|
-5405.286%
|
Evofem Biosciences, Inc.
|
10.35 USD
|
1307.44%
|
Nascent Biotech, Inc.
|
-0.01 USD
|
-932511.94%
|
Rebus Holdings, Inc.
|
-0.03 USD
|
-389214.642%
|
Santhera Pharmaceuticals Holding AG
|
5.95 USD
|
2200.336%
|
Qrons Inc.
|
-0.06 USD
|
-214256.775%
|
Adynxx, Inc.
|
- USD
|
Infinity%
|
Neon Bloom, Inc.
|
-0.00 USD
|
-8331233.333%
|
Northwest Biotherapeutics, Inc.
|
-0.06 USD
|
-217239.13%
|
ProtoKinetix, Incorporated
|
-0.01 USD
|
-1249600.0%
|
Skye Bioscience, Inc.
|
-5.37 USD
|
-2227.188%
|
Eiger BioPharmaceuticals, Inc.
|
-50.78 USD
|
-146.101%
|
Nanobac Pharmaceuticals, Incorporated
|
- USD
|
Infinity%
|
Institute of Biomedical Research Corp.
|
-0.05 USD
|
-242560.194%
|
SQZ Biotechnologies Company
|
-2.76 USD
|
-4427.899%
|
Intellipharmaceutics International Inc.
|
-0.09 USD
|
-142886.27%
|
Propanc Biopharma, Inc.
|
-0.02 USD
|
-527199.578%
|
Mesoblast Limited
|
-0.09 USD
|
-140158.137%
|
Marizyme, Inc.
|
-1.44 USD
|
-8578.472%
|
Genus plc
|
0.12 USD
|
104241.667%
|
VioQuest Pharmaceuticals, Inc.
|
-2.33 USD
|
-5263.519%
|
Pharming Group N.V.
|
-0.02 USD
|
-776111.18%
|
Therapeutic Solutions International, Inc.
|
-0.00 USD
|
-17852757.143%
|
CNBX Pharmaceuticals Inc.
|
-0.42 USD
|
-29654.762%
|
Nymox Pharmaceutical Corporation
|
-0.10 USD
|
-129402.591%
|
PsyBio Therapeutics Corp.
|
-0.04 USD
|
-297447.619%
|
Sienna Biopharmaceuticals, Inc.
|
- USD
|
Infinity%
|
RegeneRx Biopharmaceuticals, Inc.
|
-0.01 USD
|
-1041316.667%
|
IMV Inc.
|
-4.37 USD
|
-2759.725%
|
AXIM Biotechnologies, Inc.
|
-0.04 USD
|
-352922.599%
|
MultiCell Technologies, Inc.
|
-0.00 USD
|
-124969900.0%
|
ONE Bio Corp.
|
1.43 USD
|
8839.161%
|
Accustem Sciences Inc.
|
-0.34 USD
|
-36655.882%
|
RVL Pharmaceuticals plc
|
-0.58 USD
|
-21446.552%
|
Arno Therapeutics, Inc.
|
- USD
|
Infinity%
|
EV Biologics, Inc.
|
-0.12 USD
|
-104041.667%
|
Q BioMed Inc.
|
-0.08 USD
|
-159912.804%
|
Emmaus Life Sciences, Inc.
|
-0.07 USD
|
-177666.714%
|
Mosaic ImmunoEngineering Inc.
|
-0.33 USD
|
-37769.697%
|
Biomind Labs Inc.
|
-0.02 USD
|
-771319.753%
|
American Oriental Bioengineering, Inc.
|
-781.24 USD
|
84.004%
|
Provectus Biopharmaceuticals, Inc.
|
-0.01 USD
|
-1688683.784%
|
TetraLogic Pharmaceuticals Corporation
|
- USD
|
Infinity%
|
Oncotelic Therapeutics, Inc.
|
-0.02 USD
|
-627889.95%
|
GlobeStar Therapeutics Corporation
|
-0.00 USD
|
-5206983.333%
|
THC Farmaceuticals, Inc.
|
-0.00 USD
|
-15621150.0%
|
Acro Biomedical Co., Ltd.
|
-0.26 USD
|
-47965.385%
|
Curative Biotechnology, Inc.
|
-0.01 USD
|
-1420013.636%
|
GB Sciences, Inc.
|
-0.00 USD
|
-3047948.78%
|
Alpha Cognition Inc.
|
-0.15 USD
|
-83213.333%
|
HST Global, Inc.
|
-0.03 USD
|
-447821.147%
|
CSL Limited
|
2.73 USD
|
4677.656%
|
Wesana Health Holdings Inc.
|
-0.05 USD
|
-249341.118%
|
Halberd Corporation
|
-0.00 USD
|
-124969900.0%
|
Enzolytics Inc.
|
-0.00 USD
|
-17852757.143%
|
Agentix Corp.
|
-0.04 USD
|
-356957.143%
|
Resverlogix Corp.
|
-0.01 USD
|
-879970.423%
|
Nuo Therapeutics, Inc.
|
-0.08 USD
|
-165642.706%
|
MetaStat, Inc.
|
- USD
|
Infinity%
|
argenx SE
|
-5.16 USD
|
-2321.899%
|
Enzon Pharmaceuticals, Inc.
|
0.00 USD
|
9613176.923%
|
Endonovo Therapeutics, Inc.
|
0.03 USD
|
497988.446%
|
RespireRx Pharmaceuticals Inc.
|
-0.04 USD
|
-349956.022%
|
GeneThera, Inc.
|
- USD
|
Infinity%
|
Inhibitor Therapeutics, Inc.
|
-0.02 USD
|
-624750.0%
|
AVAX Technologies, Inc.
|
-0.05 USD
|
-231755.288%
|
Zenith Capital Corp.
|
-0.07 USD
|
-178683.977%
|
Genscript Biotech Corporation
|
-0.05 USD
|
-275164.317%
|
Ember Therapeutics, Inc.
|
-0.01 USD
|
-1983550.794%
|
Anthera Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
Sigyn Therapeutics, Inc.
|
-3.77 USD
|
-3214.854%
|
WPD Pharmaceuticals Inc.
|
-0.00 USD
|
-24993900.0%
|
Cotinga Pharmaceuticals Inc.
|
-0.09 USD
|
-136778.423%
|
Kadimastem Ltd
|
-0.78 USD
|
-15921.795%
|
Helix BioMedix, Inc.
|
-4.70 USD
|
-2558.936%
|
VitaSpring Biomedical Co. Ltd.
|
- USD
|
Infinity%
|
Capstone Therapeutics Corp.
|
-36.39 USD
|
-243.419%
|
BioStem Technologies, Inc.
|
-0.62 USD
|
-20056.452%
|
Oncology Pharma Inc.
|
- USD
|
Infinity%
|
Reve Technologies, Inc.
|
-0.01 USD
|
-1050068.067%
|
LadRx Corporation
|
0.68 USD
|
18477.941%
|
Cell Source, Inc.
|
-0.17 USD
|
-73411.765%
|
Regen BioPharma, Inc.
|
0.29 USD
|
43193.103%
|
Regen BioPharma, Inc.
|
0.26 USD
|
48165.385%
|
NovAccess Global Inc.
|
-0.23 USD
|
-54234.783%
|
Affymax, Inc.
|
-0.39 USD
|
-31943.59%
|
Itoco Inc.
|
-0.01 USD
|
-1644242.105%
|
Rasna Therapeutics, Inc.
|
-0.01 USD
|
-1249600.0%
|
Pathfinder Cell Therapy, Inc.
|
-0.00 USD
|
-4998700.0%
|
Mobile Lads Corp.
|
-0.01 USD
|
-2231507.143%
|
CytoDyn Inc.
|
-0.05 USD
|
-236138.185%
|
Claritas Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
NDT Pharmaceuticals Inc.
|
-0.00 USD
|
-24993900.0%
|
NanoSphere Health Sciences Inc.
|
-0.02 USD
|
-562827.928%
|
Alseres Pharmaceuticals, Inc.
|
-153.67 USD
|
18.676%
|
SYBLEU INC
|
-0.02 USD
|
-714014.286%
|
Advanced Proteome Therapeutics Corporation
|
- USD
|
Infinity%
|
ImmunoCellular Therapeutics, Ltd.
|
-0.01 USD
|
-879970.423%
|
International Stem Cell Corporation
|
-0.02 USD
|
-761912.195%
|
Bioxytran, Inc.
|
-0.03 USD
|
-391655.486%
|
GlobeImmune, Inc.
|
- USD
|
Infinity%
|
Predictive Technology Group, Inc.
|
- USD
|
Infinity%
|
ProText Mobility, Inc.
|
- USD
|
Infinity%
|
Cardax, Inc.
|
- USD
|
Infinity%
|
VG Life Sciences Inc.
|
-0.00 USD
|
-124969900.0%
|
Kaleido Biosciences, Inc.
|
- USD
|
Infinity%
|
Advaxis, Inc.
|
-7.99 USD
|
-1464.08%
|
Adhera Therapeutics, Inc.
|
-1.18 USD
|
-10490.678%
|
RenovaCare, Inc.
|
- USD
|
Infinity%
|
Regnum Corp.
|
-0.03 USD
|
-367458.824%
|
Innovation Pharmaceuticals Inc.
|
-0.01 USD
|
-1983550.794%
|
Neutra Corp.
|
-0.00 USD
|
-124969900.0%
|
Windtree Therapeutics, Inc.
|
-94.23 USD
|
-32.622%
|
PureTech Health plc
|
-2.38 USD
|
-5150.84%
|
Coeptis Therapeutics, Inc.
|
-0.83 USD
|
-14956.627%
|
IXICO plc
|
-0.02 USD
|
-512072.131%
|
IntelGenx Technologies Corp.
|
-0.06 USD
|
-219917.606%
|
Gelesis Holdings, Inc.
|
-1.35 USD
|
-9157.037%
|
CSL Limited
|
5.47 USD
|
2384.644%
|
Cellectis S.A.
|
-1.77 USD
|
-6960.452%
|